banner
EGFR-HER2 inhibitor Neratinib, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ1040

EGFR-HER2 inhibitor Neratinib, Purity ≥98%

Synonym: Neratinib; 698387-09-6; HKI-272; Neratinib (HKI-272); Nerlynx; HKI 272; UNII-JJH94R3PWB; EGFR-HER2 inhibitor

  • MDL: MFCD09752958
  • CAS Number: 698387-09-6
  • Compound CID: 9915743
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Neratinib, soluble in warmed DMSO and insoluble in water and ethanol, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR, KDR, Akt, and c-Met.
Molecular Weight
557
Molecular Formula
C30H29ClN6O3
Targets
EGFR: 92 nM; KDR: 800 nM; Akt: >20 μM; c-Met: >35 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 4 mg/mL (7.18 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Neratinib can be used to irreversibly inhibit HER2 and EGFR for research into HER2-positive breast cancer.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0